Board Meeting Details
Date: Friday, July 31, 2026
Location: Registered office of the Company
Agenda Items
1. Consider proposal for fund raising by way of issue of equity shares/convertible warrants and/or any other instruments through preferential issue. This is subject to approval of shareholders of the Company and such regulatory/statutory approvals as may be required.
2. Consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Three Months ended June 30, 2026.
3. Any other matter as Board of Directors may decide during the course of meeting.
Trading Window Disclosure
Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, the trading window for dealing in Equity Shares of the Company is closed from July 01, 2026 until 48 hours after the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 are approved by the Board of Directors and filed with the Stock Exchange.
This trading window closure applies to Promoters, Directors, Key Managerial Personnels, designated persons of the Company including their immediate relatives.